UDK 616-006
BBK 55.6
T92
Editors
Dr. sci. (med.) Sergej OSINSKY
Professor of Oncology, Department of Microenvironment of Tumor Cells,
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology
National Academy of Sciences of Ukraine, Kiev, Ukraine
Dr. med. Helmut FRIESS
Professor and Chairman, Department of Surgery, Klinikum rechts der Isar,
Technische Universitat Munchen, Munich, Germany
Dr. med. Peter VAUPEL, M.A., Univ. Harvard
Professor of Tumor Pathophysiology, Department of Radiotherapy and
Radiooncology, Klinikum rechts der Isar, Technische Universitat Munchen,
Munich, Germany
Reviewers
Academician of NAS of Ukraine V.F. CHEKHUN, academician of NAS of Ukraine A.A. MOJBENKO
Editorial assistances
Dr. D. K. Kelleher, Ph.D., University of Mainz, Germany and Dr. M. Zavelevich, Ph.D., R.E. Kavetsky Institute of Experimental Pathology, Oncology and
Radiobiology, Kiev, Ukraine
The monograph is published in accordance with recommendation of the Scientific Board of R.E. Kavetsky Institute of Experimental Pathology,
Oncology and Radiobiology (N° 8, 03 June, 2010).
Publication was made possible by a State contract promoting the production of scientific printed material.
T92
Tumor hypoxia in the clinical setting / S. Osinsky, H. Friess, P. Vaupel
(eds.). — K.: Akademperiodyka, 2011. — 272 p., 8 p. il.
ISBN 978-966-360-169-4
This monograph considers the data from pathophysiological studies of human tumors, in particular concerning the pathogenesis of tumor hypoxia and the molecular basis of its
impact on tumor aggressiveness. Special attention has been paid to the relevance of tumor hypoxia for diagnosis and treatment, as well as for the prognosis of disease outcome. Tumor
response to treatment and approaches to enhance its efficacy are considered, with special emphasis on the role played by intratumorai hypoxia. The link between the molecular mecha-
nisms of malignant growth and the pathophysiological characteristics of neoplasia is discussed using the example of human tumors.
BBK55.6